Substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives as GABA alpha 5 ligands

发明授权

US06200975B1 Substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives as GABA alpha 5 ligands 有权

标题翻译：取代的1,2,4-三唑并[3,4-a]酞嗪衍生物作为GABAα5配体

专利标题： Substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives as GABA alpha 5 ligands
专利标题（中）： 取代的1,2,4-三唑并[3,4-a]酞嗪衍生物作为GABAα5配体
申请号： US09180623

申请日： 1998-11-12
公开(公告)号： US06200975B1

公开(公告)日： 2001-03-13
发明人: William Robert Carling , Tamara Ladduwahetty , Angus Murray MacLeod , Kevin John Merchant , Kevin William Moore , Francine Sternfeld , Leslie Joseph Street
申请人： William Robert Carling , Tamara Ladduwahetty , Angus Murray MacLeod , Kevin John Merchant , Kevin William Moore , Francine Sternfeld , Leslie Joseph Street
优先权： GB9709368 19970508; GB9714508 19970710; GB9723741 19971111; GB9803992 19980225
主分类号： A61K315025
IPC分类号： A61K315025

摘要：

Substituted 1,2,4-Triazolo[3,4-A]phthalazine derivatives are GABA Alpha 5 ligands and are represented by the formula

摘要（中）：

取代的1,2,4-三唑并[3,4-A]酞嗪衍生物是GABAα5配体，由下式表示

Espacenet